Newsroom
-
Feb 7, 2012
Alliqua, Inc. Receives Healthcare Common Procedural Coding System (“HCPCS”) Code for its Silver Based Hydrogel Dressings
[More] -
Feb 1, 2012
Alliqua, Inc. Provides Corporate Update, Plans for 2012
[More] -
Oct 4, 2011
Alliqua Retains INC Research, LLC, as Strategic Consultant
[More] -
Jul 20, 2011
Correction: Alliqua, Inc. Acquires Exclusive License to Antimicrobial Wound Care Products from Noble Biomaterials, Inc.
[More] -
May 4, 2011
Alliqua, Inc. Expands Patent Portfolio for Transdermal Drug Delivery Platform
[More] -
May 3, 2011
Alliqua, Inc. Announces Preparation of IND for PHN Patch
[More] -
Apr 12, 2011
Alliqua, Inc. Files Provisional Patent in the U.S. for Transdermal Delivery System
[More] -
Mar 7, 2011
Alliqua Successfully Completes Next Milestone in Transdermal Pain Patch Development
[More] -
Mar 2, 2011
Alliqua to Announce Results of Initial Transdermal Pain Patch In Vitro Study
[More] -
Mar 2, 2011
Frost Gamma Investments Trust Makes Strategic Investment in Alliqua, Inc.
[More] -
Jan 20, 2011
Alliqua Announces the Successful Completion of its Initial Study for the Transdermal Pain Patch
[More] -
Jan 6, 2011
Alliqua Appoints Five New Directors to Its Board
[More] -
Jan 4, 2011
Alliqua Retains Industry Veteran Dr. Ronald S. Harland as Strategic Consultant
[More] -
Jan 4, 2011
Alliqua Announces Ticker Symbol Change to “ALQA” Effective January 5th
[More] -
Dec 22, 2010
HepaLife Technologies Announces Name Change to “Alliqua, Inc.”
[More] -
Nov 9, 2010
HepaLife Technologies Announces 510(k) Submission to the FDA for Its Silver Based Antimicrobial Wound Dressing
[More] -
Nov 3, 2010
HepaLife Technologies to Enter Pain Management Market with Its Transdermal Patch
[More] -
Nov 1, 2010
HepaLife Technologies Launches Alliqua BioMedical
[More]